Maria Liza Lindenberg

7PUBLICATIONS
72CO-AUTHORS
Gene and molecular therapyRadiation therapyPharmaceutical delivery technologiesPredictive and prognostic markersMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 08, 2026
SARC031: A Phase II Trial of Selumetinib and Sirolimus for Patients with Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumors (MPNST).

AeRang Kim, Karla V Ballman, Pamela L Wolters

|Oct 23, 2025
National Cancer Institute's Working Group on Biochemically Recurrent Prostate Cancer: Clinical Trial Design Considerations.

David J Einstein, Melissa L Abel, Jeanny B Aragon-Ching

|Aug 19, 2025
Phase II Study of <sup>177</sup>Lu-DOTATATE for Progressive Metastatic Pheochromocytomas and Paragangliomas: Interim Analysis of Efficacy, Safety, and Biomarkers.

Frank I Lin, Jaydira Del Rivero, Jorge A Carrasquillo

|Jul 17, 2025
Circulating Tumor Cells Are Detectable and Independent of PSA and PSMA-PET Metrics in Localized High-Risk and Biochemically Recurrent Prostate Cancer.

Shraddha Rastogi, Nahoko Sato, Sunmin Lee

|Jul 19, 2022
<sup>18</sup>F-DCFPyL PET/CT for Initially Diagnosed and Biochemically Recurrent Prostate Cancer: Prospective Trial with Pathologic Confirmation.

Gary A Ulaner, Beth Thomsen, Jeffrey Bassett

|Jun 06, 2022
With New Technology Comes Great Responsibility: Prostate-Specific Membrane Antigen Imaging in Recurrent Prostate Cancer.

Ravi A Madan, Esther Mena, Liza Lindenberg

Pageof 2

Frequent Collaborators

3 joint publications

Ravi Madan

3 joint publications

Peter L Choyke

2 joint publications

Baris Turkbey

2 joint publications

Deborah E Citrin